- Home
- RBA vs RPRX Comparison
RBA vs RPRX Comparison
Compare RBA & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBA
- RPRX
- Stock Information
- Founded
- RBA 1958
- RPRX 1996
- Country
- RBA United States
- RPRX United States
- Employees
- RBA N/A
- RPRX N/A
- Industry
- RBA Business Services
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- RBA Consumer Discretionary
- RPRX Health Care
- Exchange
- RBA Nasdaq
- RPRX Nasdaq
- Market Cap
- RBA 16.5B
- RPRX 13.6B
- IPO Year
- RBA 1998
- RPRX 2020
- Fundamental
- Price
- RBA $90.67
- RPRX $31.68
- Analyst Decision
- RBA Buy
- RPRX Strong Buy
- Analyst Count
- RBA 6
- RPRX 6
- Target Price
- RBA $98.92
- RPRX $41.67
- AVG Volume (30 Days)
- RBA 765.0K
- RPRX 4.0M
- Earning Date
- RBA 02-18-2025
- RPRX 02-11-2025
- Dividend Yield
- RBA 1.29%
- RPRX 2.78%
- EPS Growth
- RBA 90.23
- RPRX 518.56
- EPS
- RBA 1.84
- RPRX 2.55
- Revenue
- RBA $4,183,500,000.00
- RPRX $2,266,003,000.00
- Revenue This Year
- RBA $15.39
- RPRX $14.54
- Revenue Next Year
- RBA $4.31
- RPRX $10.94
- P/E Ratio
- RBA $49.00
- RPRX $12.51
- Revenue Growth
- RBA 35.71
- RPRX N/A
- 52 Week Low
- RBA $63.13
- RPRX $24.05
- 52 Week High
- RBA $99.79
- RPRX $32.21
- Technical
- Relative Strength Index (RSI)
- RBA 52.04
- RPRX 78.76
- Support Level
- RBA $89.65
- RPRX $29.73
- Resistance Level
- RBA $91.80
- RPRX $32.21
- Average True Range (ATR)
- RBA 1.33
- RPRX 0.76
- MACD
- RBA 0.24
- RPRX 0.19
- Stochastic Oscillator
- RBA 84.95
- RPRX 92.20
About RBA RB Global Inc.
RB Global operates the world's largest auction for heavy equipment. The company started as a live auctioneer of industrial equipment; since then it has greatly expanded its operations to include the sale of construction, agricultural, oilfield, and transportation equipment. RB Global operates over 40 live auction sites in more than 12 countries, along with online marketplaces, including IronPlanet, Marketplace-E, and GovPlanet. Its agricultural auctions are frequently much smaller venues and can include liquidations of single farms. The company holds over 300 auctions yearly and sells $6 billion worth of equipment.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.